Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3078)	11/30/2010 9:02:07 AM
From: Jibacoa	Respond to of 3722

SOMX will open with an UG today.<g> It announced that its senior management team will ring the NAZ opening bell on Friday, December 3, to celebrates the introduction of Silenor,which was launched in September with the help of PG.<g> Silenor is another drug for the treatment of insomnia, which reportedly affects approximately 70M people in the USA. The drug targets a neurotransmitter responsible for regulating wakefulness, and this is why SOMX claims that the drug induces a full night’s sleep without abuse potential or meaningful next-day residual effects.<g> SOMX reported a much larger loss on the 3rdQ and the L for the current Yr. is expected around $1.10 vs. $0.69 in 2009. For 2011 the EL is around $0.45 The ACTAY remains at $11 SOMX has a good amount of resistance at the $4 tp $6 level.<g> However, in spite of that and the ELs, with some good promotion, the stock can make good spikes. like the one it had on March 18-March 19 from the $4 to the $10 level.<G> bigcharts.marketwatch.com It seems that the R/R isn't bad at present levels.<g> bigcharts.marketwatch.com Bernard